Page last updated: 2024-09-04

jte 522 and Kidney Neoplasms

jte 522 has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, K; Fujiwara, J; Hayashi, I; Ishida, H; Kawauchi, A; Li, YN; Miki, T; Mizutani, Y; Nakanishi, H; Sato, N; Toiyama, D	1

Other Studies

1 other study(ies) available for jte 522 and Kidney Neoplasms

Article	Year
Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522. Urologia internationalis, 2010, Volume: 84, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Carcinoma, Renal Cell; Cyclooxygenase 2 Inhibitors; Drug Screening Assays, Antitumor; Humans; Kidney Neoplasms; Oxazoles; Tumor Cells, Cultured	2010

Article

Year

Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522.

Urologia internationalis, 2010, Volume: 84, Issue:3

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Carcinoma, Renal Cell; Cyclooxygenase 2 Inhibitors; Drug Screening Assays, Antitumor; Humans; Kidney Neoplasms; Oxazoles; Tumor Cells, Cultured

2010